Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-27

Clinical Trial Update: Bio Refine for Functional Mitral Regurgitation - a Safety & Feasibility Study [NA]

View source ↗

Summary

A safety and feasibility study investigating a Bio Refine product for treating functional mitral regurgitation, currently in recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bio Refine

Snippet

Sponsor: Bio Refine Ltd. | Conditions: Functional Mitral Regurgitation | NA | Status: RECRUITING